Corporate heavyweights tackle healthcare in the USA

5 February 2018
amazon_big

Three of the most respected corporations in America announced plans this week  to start a new company to tackle rising healthcare costs.

The three companies – Amazon, Berkshire Hathaway and JP Morgan Chase – are dominant in their respect business sectors and their chief executives – Jeff Bezos, Warren Buffett and Jamie Dimon, respectively - are true corporate rock stars, says Jim Miller, president of PharmSource, a GlobalData company. Their track records of achievement and penchant for disrupting their industries have led commentators and investors to wager that the new venture will bring major changes to the US healthcare industry.

The announcement by the three companies was vague on details, and the founders admitted that they are coming to the venture with no preconceived notions beyond the belief that something has to be done to bring health care costs under control in the USA. Indeed, in his statement Mr Bezos stated that “a beginner’s mind” was needed to bring a fresh approach to the problem.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Today's issue

Company Spotlight





More Features in Pharmaceutical